Westminster Health Forum

For booking-related queries or information on speaking please email us at info@forumsupport.co.uk, or contact us: +44 (0)1344 864796.

Priorities for improving patient safety in the NHS - strategy and regulation, learning and innovation, and responding to COVID-19

November 2020


Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF


***Full-scale policy conference taking place online***


This conference will examine the latest developments and key issues for improving patient safety in the NHS - looking beyond COVID-19, as well at current priorities in relation to the pandemic.


The discussion at a glance:


  • First Do No Harm - the impact of the publication of the Independent Medicines and Medical Devices Safety Review report
  • the first NHS Patient Safety Strategy - assessing progress and issues with implementation, and the impact of the pandemic on its delivery
  • a learning culture - latest thinking and next steps in its development in the NHS, including learning from harm and engaging with patients and families
  • COVID-19 - examining the response to the pandemic, patient and workforce safety during the crisis, tailoring approaches for at risk groups, and adapting care delivery practices - and how the experience can inform policy and practice going forward

A scan of relevant background and developments:


  • First Do No Harm - and its recommendations, including:
    • appointment of an independent Patient Safety Commissioner
    • establishment of a Redress Agency to support those who have been harmed by medicines and medical devices
    • strengthening the MHRA’s engagement with and focus on patients
    • overhauling medical device regulation and adverse event reporting, and the establishment of a central medical device database
    • expansion of the General Medical Council register to include a list of financial interests for all doctors
  • NHS Patient Safety Strategy - with the vision in the for continuously improving patient safety, with an amended timescale for the development of some of its new programmes due to COVID-19
  • We are the NHS: People Plan for 2020/21 - action for us all - ambitions to improve patient safety as it addresses workforce challenges, wellbeing and support for delivering care
  • the Patient Safety Incident Management System (DPSIMS) - being developed by NHS Improvement
  • the Health Service Safety Investigations Bill - due to be reintroduced which would establish the Health Service Safety Investigations Body (HSSIB) as a non-departmental public body to investigate patient safety incidents and make recommendations to prevent future safety failures
  • cost of claims - findings in NHS Resolution’s Annual Report and Accounts that costs are rising although the number of claims is remaining steady
  • COVID-19
    • PHE’s COVID-19: review of disparities in risks and outcomes review and COVID-19: understanding the impact on BAME communities report
    • new and alternative care methods - including the increased use of remote consultations and telemedicine
  • Safety of maternity services in England inquiry by the Health and Social Care Committee to assess recurrent failings in maternity services, with a focus on improving mother and baby safety
  • New funding to help hospitals introduce digital prescribing - £8.7m for digital patient records in hospitals announced by the Patient Safety Minister aimed at reducing errors by up to 30%

The discussion in detail:


  • The Patient Safety Strategy:
    • key issues for delivering safe care in the NHS, looking at:
      • reducing unwarranted variation
      • attracting clinicians into high risk specialties
      • technology and utilising data to reduce and prevent errors
      • implementation in local health systems
      • ways the new system can encourage the reporting of incidents and achieve a learning and not a blaming culture in the NHS
    • the Patient Safety Syllabus - its development for rollout in 2021 to ensure the workforce receives effective education, skills and training in patient safety as part of the new strategy
  • Clinical practice and operational procedures:
    • maintaining patient safety for COVID-19 patients and the workforce:
      • impact - on service delivery, continuity of care and non-urgent care
      • tailoring services - for at-risk groups, including those with underlying health conditions and from some ethnic minority backgrounds
    • Patient Safety Incident Response Framework:
      • examining development and findings from the early adopters scheme
      • working with providers on the appropriate response to patient safety incidents, and investigations which will then improve insight for learning going forward
      • local patient safety data - its analysis and use to create improved learning and practice
  • Regulation and oversight:
    • the role of regulation in improving patient safety and reducing avoidable harm
    • identification and investigation of factors leading to harm and the recommendations made as a result in improving safety and risk reduction
    • priorities for the Healthcare Safety Investigations Branch
    • the impact of COVID-19 on investigations and any lessons it has provided for the future

The agenda:


  • The impact of investigations in the NHS and the priorities of the Healthcare Safety Investigation Branch
  • Progress of improving patient safety in the NHS
  • Maintaining patient safety during COVID-19 - rapid learning to respond to the virus, continuity of care, and adapting care delivery practices
  • Delivering safe care in the NHS - preventing errors, utilising data and technology, supporting the workforce, and promoting high quality leadership
    • Learning from the voice of parents and families
    • How to improve patient safety by reducing unwarranted variation and learning from clinical negligence claims
    • The role of technology in reducing errors, enhancing care, and ensuring safety in remote healthcare and telemedicine
  • Taking forward the National Patient Safety Syllabus and supporting the workforce to deliver care safely during the presence of COVID-19
  • Learning from harm, reducing the cost of litigation in the NHS, and the impact of COVID-19
  • Assessing findings from the Independent Medicines and Medical Devices Safety Review
  • The role of the regulator in reducing avoidable harm and informing future practice

Policy officials attending:


Our forums are known for attracting strong interest from policymakers and stakeholders. Places have been reserved by representatives from the Department of Health and Social Care; the Government Legal Service; MHRA and the Welsh Government.


This is a full-scale conference taking place online***


  • full, four-hour programme including comfort breaks - you’ll also get a full recording to refer back to
  • information-rich discussion involving key policymakers and stakeholders
  • conference materials provided in advance, including speaker biographies
  • speakers presenting via webcam, accompanied by slides if they wish, using the Cisco WebEx professional online conference platform (easy for delegates - we’ll provide full details)
  • opportunities for live delegate questions and comments with all speakers
  • a recording of the addresses, all slides cleared by speakers, and further materials, is made available to all delegates afterwards as a permanent record of the proceedings
  • delegates are able to add their own written comments and articles following the conference, to be distributed to all attendees and more widely
  • networking too - there will be opportunities for delegates to e-meet and interact - we’ll tell you how!

Full information and guidance on how to take part will be sent to delegates before the conference



This pack includes

  • Dropbox video recording of the conference
  • PDF transcript of the discussion, including all speaker remarks and Q&A
  • PDFs of speakers' slide material (subject to permission)
  • PDFs of the delegate pack, including speaker biographies and attendee list
  • PDFs of delegate articles